Recurrence of Macular Edema in Branch Retinal Vein Occlusion
Ophthalmology Retina · 2025
DOI: 10.1016/j.oret.2025.05.012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Anna Cullhed Farrell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Karolinska Institutet, Division of Eye and Vision, Stockholm, Sweden; Vitreoretinal Department, St. Erik Eye Hos…. Hauptthemen laut MEDLINE: Ranibizumab, Macular Edema, Recombinant Fusion Proteins, Retinal Vein Occlusion. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Karolinska Institutet, Division of Eye and Vision, Stockholm, Sweden; Vitreoretinal Department, St. Erik Eye Hospital, Stockholm, Sweden. Electronic address: anna.cullhed-farrell@reg…
- Department of Clinical Neuroscience, Karolinska Institutet, Division of Eye and Vision, Stockholm, Sweden; Vitreoretinal Department, St. Erik Eye Hospital, Stockholm, Sweden.
- Vitreoretinal Department, St. Erik Eye Hospital, Stockholm, Sweden.
Zitieren
APA
Cullhed Farrell, A., Casselholm de Salles, M., Lindberg, C., & Epstein, D. (2025). Recurrence of Macular Edema in Branch Retinal Vein Occlusion. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2025.05.012
Vancouver
Cullhed Farrell A, Casselholm de Salles M, Lindberg C, Epstein D. Recurrence of Macular Edema in Branch Retinal Vein Occlusion. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2025.05.012
BibTeX
@article{CullhedFarrell2025,
author = {Cullhed Farrell, Anna and Casselholm de Salles, Manuel and Lindberg, Charlotte and Epstein, David},
title = {Recurrence of Macular Edema in Branch Retinal Vein Occlusion},
journal = {Ophthalmology Retina},
year = {2025},
doi = {10.1016/j.oret.2025.05.012}
}
EUVIMED